Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.

Marcotte H, Larsson PG, Andersen KK, Zuo F, Mikkelsen LS, Brandsborg E, Gray G, Laher F, Otwombe K.

BMC Infect Dis. 2019 Sep 18;19(1):824. doi: 10.1186/s12879-019-4425-1.

2.

Putative Adhesion Factors in Vaginal Lactobacillus gasseri DSM 14869: Functional Characterization.

Zeng Z, Zuo F, Marcotte H.

Appl Environ Microbiol. 2019 Sep 17;85(19). pii: e00800-19. doi: 10.1128/AEM.00800-19. Print 2019 Oct 1.

PMID:
31420338
3.

Inducible Plasmid Self-Destruction (IPSD) Assisted Genome Engineering in Lactobacilli and Bifidobacteria.

Zuo F, Zeng Z, Hammarström L, Marcotte H.

ACS Synth Biol. 2019 Aug 16;8(8):1723-1729. doi: 10.1021/acssynbio.9b00114. Epub 2019 Jul 12.

PMID:
31277549
4.

Clostridium difficile, the Difficult "Kloster" Fuelled by Antibiotics.

Dicks LMT, Mikkelsen LS, Brandsborg E, Marcotte H.

Curr Microbiol. 2019 Jun;76(6):774-782. doi: 10.1007/s00284-018-1543-8. Epub 2018 Aug 6. Review.

PMID:
30084095
5.

Our gut microbiota: a long walk to homeostasis.

Dicks LMT, Geldenhuys J, Mikkelsen LS, Brandsborg E, Marcotte H.

Benef Microbes. 2018 Jan 29;9(1):3-20. doi: 10.3920/BM2017.0066. Epub 2017 Oct 12. Review.

PMID:
29022388
6.

Characterization and complete genome sequences of L. rhamnosus DSM 14870 and L. gasseri DSM 14869 contained in the EcoVag® probiotic vaginal capsules.

Marcotte H, Krogh Andersen K, Lin Y, Zuo F, Zeng Z, Larsson PG, Brandsborg E, Brønstad G, Hammarström L.

Microbiol Res. 2017 Dec;205:88-98. doi: 10.1016/j.micres.2017.08.003. Epub 2017 Aug 14.

7.

Lactobacillus delivery of bioactive interleukin-22.

Lin Y, Krogh-Andersen K, Hammarström L, Marcotte H.

Microb Cell Fact. 2017 Aug 23;16(1):148. doi: 10.1186/s12934-017-0762-1.

8.

Oral Delivery of Pentameric Glucagon-Like Peptide-1 by Recombinant Lactobacillus in Diabetic Rats.

Lin Y, Krogh-Andersen K, Pelletier J, Marcotte H, Östenson CG, Hammarström L.

PLoS One. 2016 Sep 9;11(9):e0162733. doi: 10.1371/journal.pone.0162733. eCollection 2016.

9.

Fusion of the mouse IgG1 Fc domain to the VHH fragment (ARP1) enhances protection in a mouse model of rotavirus.

Günaydın G, Yu S, Gräslund T, Hammarström L, Marcotte H.

Sci Rep. 2016 Jul 21;6:30171. doi: 10.1038/srep30171.

10.

Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies.

Andersen KK, Strokappe NM, Hultberg A, Truusalu K, Smidt I, Mikelsaar RH, Mikelsaar M, Verrips T, Hammarström L, Marcotte H.

Infect Immun. 2015 Nov 16;84(2):395-406. doi: 10.1128/IAI.00870-15. Print 2016 Feb.

11.

Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.

Pendharkar S, Brandsborg E, Hammarström L, Marcotte H, Larsson PG.

BMC Infect Dis. 2015 Jul 3;15:255. doi: 10.1186/s12879-015-0971-3.

12.

An Exopolysaccharide-Deficient Mutant of Lactobacillus rhamnosus GG Efficiently Displays a Protective Llama Antibody Fragment against Rotavirus on Its Surface.

Álvarez B, Krogh-Andersen K, Tellgren-Roth C, Martínez N, Günaydın G, Lin Y, Martín MC, Álvarez MA, Hammarström L, Marcotte H.

Appl Environ Microbiol. 2015 Sep 1;81(17):5784-93. doi: 10.1128/AEM.00945-15. Epub 2015 Jun 19.

13.

Co-expression of anti-rotavirus proteins (llama VHH antibody fragments) in Lactobacillus: development and functionality of vectors containing two expression cassettes in tandem.

Günaydın G, Alvarez B, Lin Y, Hammarström L, Marcotte H.

PLoS One. 2014 Apr 29;9(4):e96409. doi: 10.1371/journal.pone.0096409. eCollection 2014.

14.

Engineered Lactobacillus rhamnosus GG expressing IgG-binding domains of protein G: Capture of hyperimmune bovine colostrum antibodies and protection against diarrhea in a mouse pup rotavirus infection model.

Günaydın G, Zhang R, Hammarström L, Marcotte H.

Vaccine. 2014 Jan 16;32(4):470-7. doi: 10.1016/j.vaccine.2013.11.057. Epub 2013 Nov 27.

PMID:
24291196
15.

Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection.

Tokuhara D, Álvarez B, Mejima M, Hiroiwa T, Takahashi Y, Kurokawa S, Kuroda M, Oyama M, Kozuka-Hata H, Nochi T, Sagara H, Aladin F, Marcotte H, Frenken LG, Iturriza-Gómara M, Kiyono H, Hammarström L, Yuki Y.

J Clin Invest. 2013 Sep;123(9):3829-38. doi: 10.1172/JCI70266. Epub 2013 Aug 8.

16.

Identification and characterisation of vaginal lactobacilli from South African women.

Pendharkar S, Magopane T, Larsson PG, de Bruyn G, Gray GE, Hammarström L, Marcotte H.

BMC Infect Dis. 2013 Jan 26;13:43. doi: 10.1186/1471-2334-13-43.

17.

In situ gastrointestinal protection against anthrax edema toxin by single-chain antibody fragment producing lactobacilli.

Andersen KK, Marcotte H, Álvarez B, Boyaka PN, Hammarström L.

BMC Biotechnol. 2011 Dec 20;11:126. doi: 10.1186/1472-6750-11-126.

18.

Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses.

Larsson PG, Brandsborg E, Forsum U, Pendharkar S, Andersen KK, Nasic S, Hammarström L, Marcotte H.

BMC Infect Dis. 2011 Aug 19;11:223. doi: 10.1186/1471-2334-11-223.

19.

Safety and persistence of orally administered human Lactobacillus sp. strains in healthy adults.

Hütt P, Kõll P, Stsepetova J, Alvarez B, Mändar R, Krogh-Andersen K, Marcotte H, Hammarström L, Mikelsaar M.

Benef Microbes. 2011 Mar;2(1):79-90. doi: 10.3920/BM2010.0023.

PMID:
21831792
20.

Lactobacilli producing bispecific llama-derived anti-rotavirus proteins in vivo for rotavirus-induced diarrhea.

Pant N, Marcotte H, Hermans P, Bezemer S, Frenken L, Johansen K, Hammarström L.

Future Microbiol. 2011 May;6(5):583-93. doi: 10.2217/fmb.11.32.

PMID:
21585264
21.

Integrative expression system for delivery of antibody fragments by lactobacilli.

Martín MC, Pant N, Ladero V, Günaydin G, Andersen KK, Alvarez B, Martínez N, Alvarez MA, Hammarström L, Marcotte H.

Appl Environ Microbiol. 2011 Mar;77(6):2174-9. doi: 10.1128/AEM.02690-10. Epub 2011 Jan 21.

22.

Screening and evaluation of human intestinal lactobacilli for the development of novel gastrointestinal probiotics.

Kõll P, Mändar R, Smidt I, Hütt P, Truusalu K, Mikelsaar RH, Shchepetova J, Krogh-Andersen K, Marcotte H, Hammarström L, Mikelsaar M.

Curr Microbiol. 2010 Dec;61(6):560-6. doi: 10.1007/s00284-010-9653-y. Epub 2010 May 5.

PMID:
20443005
23.

Characterization of oral lactobacilli as potential probiotics for oral health.

Kõll P, Mändar R, Marcotte H, Leibur E, Mikelsaar M, Hammarström L.

Oral Microbiol Immunol. 2008 Apr;23(2):139-47. doi: 10.1111/j.1399-302X.2007.00402.x.

PMID:
18279182
24.

Effective prophylaxis against rotavirus diarrhea using a combination of Lactobacillus rhamnosus GG and antibodies.

Pant N, Marcotte H, Brüssow H, Svensson L, Hammarström L.

BMC Microbiol. 2007 Sep 27;7:86.

25.

Lactobacillli expressing llama VHH fragments neutralise Lactococcus phages.

Hultberg A, Tremblay DM, de Haard H, Verrips T, Moineau S, Hammarström L, Marcotte H.

BMC Biotechnol. 2007 Sep 17;7:58.

26.

Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea.

Pant N, Hultberg A, Zhao Y, Svensson L, Pan-Hammarstrom Q, Johansen K, Pouwels PH, Ruggeri FM, Hermans P, Frenken L, Boren T, Marcotte H, Hammarstrom L.

J Infect Dis. 2006 Dec 1;194(11):1580-8. Epub 2006 Oct 23.

PMID:
17083044
27.

Therapeutic effect of llama derived VHH fragments against Streptococcus mutans on the development of dental caries.

Krüger C, Hultberg A, Marcotte H, Hermans P, Bezemer S, Frenken LG, Hammarström L.

Appl Microbiol Biotechnol. 2006 Oct;72(4):732-7. Epub 2006 Apr 25.

PMID:
16636830
28.

Expression of single-chain antibody against RgpA protease of Porphyromonas gingivalis in Lactobacillus.

Marcotte H, Kõll-Klais P, Hultberg A, Zhao Y, Gmür R, Mändar R, Mikelsaar M, Hammarström L.

J Appl Microbiol. 2006 Feb;100(2):256-63.

29.

Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity.

Kõll-Klais P, Mändar R, Leibur E, Marcotte H, Hammarström L, Mikelsaar M.

Oral Microbiol Immunol. 2005 Dec;20(6):354-61.

PMID:
16238595
30.

Passive immunization by lactobacilli expressing single-chain antibodies against Streptococcus mutans.

Krüger C, Hultberg A, van Dollenweerd C, Marcotte H, Hammarström L.

Mol Biotechnol. 2005 Nov;31(3):221-31.

PMID:
16230772
31.

The aggregation-promoting factor of Lactobacillus crispatus M247 and its genetic locus.

Marcotte H, Ferrari S, Cesena C, Hammarström L, Morelli L, Pozzi G, Oggioni MR.

J Appl Microbiol. 2004;97(4):749-56.

32.

Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C.

Robinson K, Chamberlain LM, Lopez MC, Rush CM, Marcotte H, Le Page RW, Wells JM.

Infect Immun. 2004 May;72(5):2753-61.

33.

In situ delivery of passive immunity by lactobacilli producing single-chain antibodies.

Krüger C, Hu Y, Pan Q, Marcotte H, Hultberg A, Delwar D, van Dalen PJ, Pouwels PH, Leer RJ, Kelly CG, van Dollenweerd C, Ma JK, Hammarström L.

Nat Biotechnol. 2002 Jul;20(7):702-6.

PMID:
12089555
34.

Voriconazole and fluconazole susceptibility of Candida isolates.

Pelletier R, Loranger L, Marcotte H, De Carolis E.

J Med Microbiol. 2002 Jun;51(6):479-83.

PMID:
12018654
35.

Immunoglobulin-binding domains of peptostreptococcal protein L enhance vaginal colonization of mice by Streptococcus gordonii.

Ricci S, Medaglini D, Marcotte H, Olsén A, Pozzi G, Björck L.

Microb Pathog. 2001 Apr;30(4):229-35.

PMID:
11312616
36.

Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice.

Medaglini D, Ciabattini A, Spinosa MR, Maggi T, Marcotte H, Oggioni MR, Pozzi G.

Vaccine. 2001 Feb 28;19(15-16):1931-9.

PMID:
11228363
37.

Oral microbial ecology and the role of salivary immunoglobulin A.

Marcotte H, Lavoie MC.

Microbiol Mol Biol Rev. 1998 Mar;62(1):71-109. Review.

38.
39.
40.

Pneumocystis carinii infection in transgenic B cell-deficient mice.

Marcotte H, Levesque D, Delanay K, Bourgeault A, de la Durantaye R, Brochu S, Lavoie MC.

J Infect Dis. 1996 Apr;173(4):1034-7.

PMID:
8603947
41.

Colonization of the oral cavity of mice by an unidentified streptococcus.

Marcotte H, Rodrigue L, Coulombe C, Goyette N, Lavoie MC.

Oral Microbiol Immunol. 1995 Jun;10(3):168-74.

PMID:
7567066
42.

Immunization against the oral indigenous bacteria of the BALB/c mouse.

Marcotte H, Rodrigue L, Gamache M, Lavoie MC.

Adv Exp Med Biol. 1995;371B:1173-6. No abstract available.

PMID:
7502778
43.

Bacterial colonization of the oral cavity of the BALB/c mouse.

Rodrigue L, Barras MJ, Marcotte H, Lavoie MC.

Microb Ecol. 1993 Nov;26(3):267-75. doi: 10.1007/BF00176958.

PMID:
24190095
44.

Evaluation of mouse salivary IgA directed against indigenous oral bacteria.

Marcotte H, Lavoie MC.

J Immunoassay. 1993 Mar-Jun;14(1-2):63-81.

PMID:
8315029
45.

Computer simulation of human mitral valve mechanics and motion.

Miller GE, Marcotte H.

Comput Biol Med. 1987;17(5):305-19.

PMID:
3677619
46.

Fluorine and its effect on teeth.

MARCOTTE HI.

J Maine Med Assoc. 1949 Apr;40(4):77. No abstract available.

PMID:
18119443

Supplemental Content

Loading ...
Support Center